William Moore, MD
Gynecology · Alexander City, ALNPI 1700804242
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,664 of the $1,898 with a category attached, or 87.7%. It is spread thinly across 31 manufacturers, the largest accounting for just 12.9% — the pattern of someone who eats at a lot of different presentations.
Across 87 payments — averaging $21.81 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sumitomo Pharma America, Inc.$245
- Coloplast$243
- Medtronic$185
- AbbVie$184
- Pfizer$152
- Astellas Pharma US Inc$93
- plus $796 from 25 others
What the payments were for
- Travel & lodging$22212%
- Food & beverage$1,66488%
- Education$121%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sumitomo Pharma America, Inc. | 14 | $245 |
| Coloplast | 2 | $243 |
| Medtronic(2 entities) | 8 | $185 |
| AbbVie | 6 | $184 |
| Pfizer | 8 | $152 |
| Astellas Pharma US Inc | 5 | $93 |
| Axonics, Inc. | 4 | $80 |
| Exeltis, USA Inc. | 3 | $71 |
| Amgen | 4 | $69 |
| Organon | 3 | $58 |
| Therapeuticsmd, Inc. | 3 | $53 |
| Mayne Pharma Commercial LLC | 3 | $45 |
| Aspira Women's Health Inc | 1 | $38 |
| Johnson & Johnson | 2 | $37 |
| Hologic Sales And Service, LLC | 2 | $37 |
| Novo Nordisk | 2 | $33 |
| Boehringer Ingelheim | 2 | $32 |
| Mylan Pharmaceuticals Inc. | 2 | $30 |
| Pharmacosmos Therapeutics Inc. | 1 | $24 |
| Insulet Corporation | 1 | $23 |
| Boston Scientific | 1 | $20 |
| Intuitive Surgical | 1 | $17 |
| Minerva Surgical, Inc | 1 | $17 |
| Radius Health, Inc. | 1 | $16 |
| Supernus Pharmaceuticals, Inc. | 1 | $16 |
| Sage Therapeutics, LLC | 1 | $16 |
| Merck | 1 | $14 |
| Shield Therapeutics Inc | 1 | $14 |
| Avion Pharmaceuticals | 1 | $12 |
| Myovant Sciences Inc. | 1 | $12 |
| AMAG Pharmaceuticals, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ALTIS$222
How this compares
$1,898 in reported general payments places this provider in the 80th percentile of 51 gynecology providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MyrbetriqMirabegron | 115 | $68,708 |
| GemtesaVibegron | 21 | $9,708 |
| Estradiol | 113 | $6,084 |
| Fosfomycin Tromethamine | 14 | $4,049 |
| Climara ProEstradiol/Levonorgestrel | 12 | $3,087 |
| Trospium Chloride | 32 | $2,493 |
| Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst | 75 | $2,490 |
| DottiEstradiol | 28 | $2,433 |
| Norethindrone Acetate | 31 | $1,302 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $1,121 |
| Solifenacin Succinate | 22 | $922 |
| ValacyclovirValacyclovir Hcl | 15 | $572 |
| Oxybutynin Chloride ErOxybutynin Chloride | 37 | $419 |
| Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip | 15 | $374 |
| Pregabalin | 14 | $287 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Astellas Pharma US IncMyrbetriq | $93 | $68,708115 claims |
| Sumitomo Pharma America, Inc.Gemtesa | $245 | $9,70821 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 51 gynecology providers in Alabama.
Other gynecology in Alexander City
- Katherine CooperAlexander City$457
- James HamiltonAlexander City$316
- Holly RichterBirmingham$22K
- Alex ChildsBirmingham$9K
- Gena DunivanBirmingham$7K
- James DockeryMontgomery$6K
- John PorterMontgomery$5K
- Judi JehleMontgomery$5K
- Glenn GallaspyMobile$4K
- William SummersBirmingham$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.